» Articles » PMID: 29123246

Transport of Drugs from Blood Vessels to Tumour Tissue

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2017 Nov 11
PMID 29123246
Citations 241
Authors
Affiliations
Soon will be listed here.
Abstract

The effectiveness of anticancer drugs in treating a solid tumour is dependent on delivery of the drug to virtually all cancer cells in the tumour. The distribution of drug in tumour tissue depends on the plasma pharmacokinetics, the structure and function of the tumour vasculature and the transport properties of the drug as it moves through microvessel walls and in the extravascular tissue. The aim of this Review is to provide a broad, balanced perspective on the current understanding of drug transport to tumour cells and on the progress in developing methods to enhance drug delivery. First, the fundamental processes of solute transport in blood and tissue by convection and diffusion are reviewed, including the dependence of penetration distance from vessels into tissue on solute binding or uptake in tissue. The effects of the abnormal characteristics of tumour vasculature and extravascular tissue on these transport properties are then discussed. Finally, methods for overcoming limitations in drug transport and thereby achieving improved therapeutic results are surveyed.

Citing Articles

Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria.

Bolliger M, Wasinger D, Brunmair J, Hagn G, Wolf M, Preindl K EPMA J. 2025; 16(1):165-182.

PMID: 39991101 PMC: 11842658. DOI: 10.1007/s13167-025-00396-6.


Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer.

Harkos C, Hadjigeorgiou A, Voutouri C, Kumar A, Stylianopoulos T, Jain R Nat Rev Cancer. 2025; .

PMID: 39972158 DOI: 10.1038/s41568-025-00796-w.


Lipid Nanoparticle Delivery System for Normalization of Tumor Microenvironment and Tumor Vascular Structure.

Ha H, Choi Y, Kim N, Kim J, Jang J, Niepa T Biomater Res. 2025; 29:0144.

PMID: 39935791 PMC: 11811622. DOI: 10.34133/bmr.0144.


In-silico tool based on Boolean networks and meshless simulations for prediction of reaction and transport mechanisms in the systemic administration of chemotherapeutic drugs.

Velez Salazar F, Patino I PLoS One. 2025; 20(2):e0315194.

PMID: 39919263 PMC: 11805580. DOI: 10.1371/journal.pone.0315194.


A bioprinted animal patient-derived breast cancer model for anti-cancer drug screening.

Mei X, Uribe Estrada M, Rizwan M, Lukin I, Sanchez Gonzalez B, Marin Canchola J Mater Today Bio. 2025; 31:101449.

PMID: 39896287 PMC: 11782996. DOI: 10.1016/j.mtbio.2025.101449.


References
1.
Dewhirst M, Ong E, Braun R, Smith B, Klitzman B, Evans S . Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer. 1999; 79(11-12):1717-22. PMC: 2362789. DOI: 10.1038/sj.bjc.6690273. View

2.
Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C . Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999; 126(14):3047-55. DOI: 10.1242/dev.126.14.3047. View

3.
Boucher Y, Brekken C, Suit H, Jain R . Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res. 1999; 59(15):3776-82. View

4.
Krol A, Maresca J, Dewhirst M, Yuan F . Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery. Cancer Res. 1999; 59(16):4136-41. View

5.
Kong G, Dewhirst M . Hyperthermia and liposomes. Int J Hyperthermia. 1999; 15(5):345-70. DOI: 10.1080/026567399285558. View